SCHEMBL14026652

SCHEMBL14026652

CCc1ccc(Oc2ccc(C(N)=O)cn2)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NNMT P40261 3/20 0.50
OPRM1 P35372 14/20 0.48
OPRK1 P41145 11/20 0.48
OPRD1 P41143 10/20 0.48
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
GRIN1 Q05586 1/20 0.44
KCNH2 Q12809 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
ROCK1 Q13464 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14026654 0.93 NNMT (0.50) NNMTOPRM1OPRK1OPRD1GRIN2D
SCHEMBL14026648 0.90 OPRM1 (0.48) NNMTOPRM1OPRK1OPRD1GRIN2D
SCHEMBL13242174 0.88 OPRM1 (0.50) NNMTOPRM1OPRK1OPRD1GRIN2D
SCHEMBL2987688 0.85 OPRM1 (0.47) NNMTOPRM1OPRK1OPRD1GRIN2D
SCHEMBL2986485 0.85 OPRM1 (0.47) NNMTOPRM1OPRK1OPRD1LMNA
SCHEMBL2997226 0.84 OPRM1 (0.48) NNMTOPRM1OPRK1OPRD1GRIN2D
SCHEMBL2994101 0.83 OPRM1 (0.67) OPRM1OPRK1OPRD1GRIN2DGRIN3B
SCHEMBL2993935 0.83 OPRM1 (0.49) OPRM1OPRK1OPRD1
SCHEMBL2987597 0.83 OPRM1 (0.44) NNMTOPRM1OPRK1OPRD1KCNH2
SCHEMBL2990579 0.83 OPRM1 (0.49) OPRM1OPRK1OPRD1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008142454-A1 BICYCLIC ARYL AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2008-11-27 WO disclosed